IL290289B2 - Hybrid amide history of amphotericin B - Google Patents

Hybrid amide history of amphotericin B

Info

Publication number
IL290289B2
IL290289B2 IL290289A IL29028922A IL290289B2 IL 290289 B2 IL290289 B2 IL 290289B2 IL 290289 A IL290289 A IL 290289A IL 29028922 A IL29028922 A IL 29028922A IL 290289 B2 IL290289 B2 IL 290289B2
Authority
IL
Israel
Prior art keywords
amphotericin
amide derivatives
hybrid amide
hybrid
derivatives
Prior art date
Application number
IL290289A
Other languages
English (en)
Hebrew (he)
Other versions
IL290289A (en
IL290289B1 (en
Original Assignee
Univ Illinois
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Illinois filed Critical Univ Illinois
Publication of IL290289A publication Critical patent/IL290289A/en
Publication of IL290289B1 publication Critical patent/IL290289B1/en
Publication of IL290289B2 publication Critical patent/IL290289B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL290289A 2019-08-08 2020-08-10 Hybrid amide history of amphotericin B IL290289B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962884464P 2019-08-08 2019-08-08
US201962951753P 2019-12-20 2019-12-20
PCT/US2020/045566 WO2021026520A1 (en) 2019-08-08 2020-08-10 Hybrid amide derivatives of amphotericin b

Publications (3)

Publication Number Publication Date
IL290289A IL290289A (en) 2022-04-01
IL290289B1 IL290289B1 (en) 2025-11-01
IL290289B2 true IL290289B2 (en) 2026-03-01

Family

ID=74503735

Family Applications (1)

Application Number Title Priority Date Filing Date
IL290289A IL290289B2 (en) 2019-08-08 2020-08-10 Hybrid amide history of amphotericin B

Country Status (12)

Country Link
US (1) US20230016424A1 (https=)
EP (1) EP4009985A4 (https=)
JP (1) JP7636004B2 (https=)
KR (1) KR20220071185A (https=)
CN (1) CN114555094A (https=)
AU (1) AU2020325163B2 (https=)
BR (1) BR112022001866A2 (https=)
CA (1) CA3149916A1 (https=)
CL (1) CL2022000319A1 (https=)
IL (1) IL290289B2 (https=)
MX (1) MX2022001678A (https=)
WO (1) WO2021026520A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH12022551513A1 (en) 2019-12-20 2023-04-24 Mirati Therapeutics Inc Sos1 inhibitors
AU2021325676A1 (en) * 2020-08-10 2023-03-30 The Board Of Trustees Of The University Of Illinois Hybrid amide derivatives of amphotericin B
CN115536716B (zh) * 2021-06-29 2025-08-08 中国科学院上海药物研究所 两性霉素b半合成衍生物及其制备方法和用途
TW202519239A (zh) * 2023-07-19 2025-05-16 美國伊利諾大學理事會 利用遺失蛋白質（ｍｉｓｓｉｎｇ ｐｒｏｔｅｉｎｓ）之小分子模擬物恢復生理機能
GB202406857D0 (en) * 2024-05-15 2024-06-26 Univ Manchester Polyenes

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4783527A (en) * 1979-04-09 1988-11-08 Politechnika Gdanska Amides of amphoteric polyene macrolide antibiotics
WO2001091758A1 (en) * 2000-05-31 2001-12-06 Intrabiotics Pharmaceuticals, Inc. Water-soluble amide derivatives of polyene macrolides and preparation and uses thereof
WO2012085784A2 (en) * 2010-12-21 2012-06-28 Centro De Investigación Y De Estudios Avanzados Del Instituto Politécnico Nacional New amphotericin analogous compounds and pharmaceutical compositions containing them
WO2016168568A1 (en) * 2015-04-15 2016-10-20 Revolution Medicines, Inc. Derivatives of amphotericin b
US20170042923A1 (en) * 2015-08-10 2017-02-16 Lehigh University Reduced toxicity molecular conjugates of anti-fungal agents

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2776927B1 (fr) * 1998-04-07 2002-07-05 Univ Paris Curie Compositions pour la vectorisation de molecules
KR20150027217A (ko) * 2012-06-15 2015-03-11 블러트 에스.에이. 항진균성 항생 암포테리신 b의 n-치환된 제2 세대 유도체, 및 이의 제조 및 응용 방법
WO2015164289A1 (en) * 2014-04-21 2015-10-29 Cidara Therapeutics, Inc. Compositions and methods for the treatment of fungal infections
ES2749927T3 (es) * 2014-05-16 2020-03-24 Univ Illinois Derivado de anfotericina b con toxicidad reducida
MA39568A1 (fr) * 2014-06-12 2017-09-29 Shionogi & Co Dérivé de macrolide de polyène
WO2016112260A1 (en) * 2015-01-08 2016-07-14 The Board Of Trustees Of The University Of Illinois Concise synthesis of urea derivatives of amphotericin b
RU2688658C1 (ru) * 2018-04-10 2019-05-22 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт по изысканию новых антибиотиков имени Г.Ф. Гаузе" Противогрибковый полусинтетический полиеновый антибиотик, его водорастворимые соли и фармацевтические композиции на их основе
TW202415384A (zh) * 2022-06-24 2024-04-16 美國伊利諾大學理事會 雙性黴素b之複合醯胺衍生物於dsgpeg2k微胞中之調配物

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4783527A (en) * 1979-04-09 1988-11-08 Politechnika Gdanska Amides of amphoteric polyene macrolide antibiotics
WO2001091758A1 (en) * 2000-05-31 2001-12-06 Intrabiotics Pharmaceuticals, Inc. Water-soluble amide derivatives of polyene macrolides and preparation and uses thereof
WO2012085784A2 (en) * 2010-12-21 2012-06-28 Centro De Investigación Y De Estudios Avanzados Del Instituto Politécnico Nacional New amphotericin analogous compounds and pharmaceutical compositions containing them
WO2016168568A1 (en) * 2015-04-15 2016-10-20 Revolution Medicines, Inc. Derivatives of amphotericin b
US20170042923A1 (en) * 2015-08-10 2017-02-16 Lehigh University Reduced toxicity molecular conjugates of anti-fungal agents

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
FALKOWSKI LEONARD ET AL:, THE SYNTHESIS OF AMIDES OF POLYENE MACROLIDE ANTIBIOTICS, 31 December 1980 (1980-12-31) *
JARZEBSKI A ET AL:, SYNTHESIS AND STRUCTURE-ACTIVITY RELATIONSHIPS OF AMIDES OF AMPHOTERICIN B, 31 December 1982 (1982-12-31) *
MITCHELL P. CROATT ET AL:, PROBING THE ROLE OF THE MYCOSAMINE C2& PRIME;- OH ON THE ACTIVITY OF AMPHOTERICIN B, 18 March 2011 (2011-03-18) *
VALERIE PAQUET ET AL:, SYNTHESIS AND IN VITRO BIOLOGICAL PROPERTIES OF NOVEL CATIONIC DERIVATIVES OF AMPHOTERICIN B, 14 January 2008 (2008-01-14) *

Also Published As

Publication number Publication date
CN114555094A (zh) 2022-05-27
CA3149916A1 (en) 2021-02-11
IL290289A (en) 2022-04-01
CL2022000319A1 (es) 2022-10-21
WO2021026520A1 (en) 2021-02-11
IL290289B1 (en) 2025-11-01
EP4009985A1 (en) 2022-06-15
EP4009985A4 (en) 2023-09-06
MX2022001678A (es) 2022-05-18
JP7636004B2 (ja) 2025-02-26
AU2020325163B2 (en) 2026-04-23
BR112022001866A2 (pt) 2022-03-29
JP2022543420A (ja) 2022-10-12
KR20220071185A (ko) 2022-05-31
US20230016424A1 (en) 2023-01-19
AU2020325163A1 (en) 2022-03-03

Similar Documents

Publication Publication Date Title
IL290289B2 (en) Hybrid amide history of amphotericin B
CA190073S (en) Earphones
CA208080S (en) Earbud charging case
CA190077S (en) Earphones
HUE070924T2 (hu) 2-Hidroxicikloalkán-1-karbamoil-származékok
CA194212S (en) Pair of earphones
CA190029S (en) Stand-alone charger
IL290815A (en) History of alpha-d-galactopyranoside
IL276592A (en) History of Subtirum
PL4077334T3 (pl) Pochodne furoindazolu
PT3283171T (pt) Derivados de anfotericina b
ZA202106024B (en) Heterocyclic derivatives
CA190012S (en) Earphones
IL291273A (en) Intranasal administration of asketamine
GB2584272B (en) Sensor synchronization
DK3992523T3 (en) Scenelampe med trådløst strømsignaltransmissionssystem
GB2583406B (en) Headset
GB201915793D0 (en) An exhaust nozzle
SG11202108905UA (en) Crystalline form of an avibactam derivative
GB201915790D0 (en) An exhaust nozzle
ZA202105399B (en) Use of spiropidion
GB201919210D0 (en) Dihydro-cyclopenta-isoquinoline derivatives
CA188709S (en) Headphones
GB2603706B (en) Detection of LARP1
GB201912411D0 (en) Crystalline forms of ivosidenib